Pulmonary vein stenosis should be suspected and evaluated when hemoptysis occurs several months after cryoballoon ablation for atrial fibrillation.
Highlights delayed hemoptysis as a critical red flag for pulmonary vein stenosis post-ablation.
Cryoballoon ablation with pulmonary vein isolation is a novel technology for the treatment of atrial fibrillation. Its efficacy was established after the introduction of the second-generation cryoballoon (CB-2).1 Cryothermal energy is known to be safer than other energy sources.2 However, some reports have shown an increasing rate of phrenic nerve palsy and elevated myocardial biomarker levels after CB-2 ablation compared with ablation using the first-generation cryoballoon (CB-1).3,4 The long-term safety of the CB-2 is not well known.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: